Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
G-protein coupled opioid receptor that functions as receptor for endogenous alpha-neoendorphins and dynorphins, but has low affinity for beta-endorphins. Also functions as receptor for various synthetic opioids and for the psychoactive diterpene salvinorin A. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain. Plays a role in mediating reduced physical activity upon treatment with synthetic opioids. Plays a role in the regulation of salivation in response to synthetic opioids. May play a role in arousal and regulation of autonomic and neuroendocrine functions.
Gene Name: | opioid receptor, kappa 1 |
Family/Subfamily: | GPCR , Opioid |
Synonyms: | OPRK1, Kappa-type opioid receptor, Opiate receptor, kappa-1, K-OR-1, KOR, Opioid receptor, kappa 1, OPRK, Ork1, Kappa opioid receptor, KOR-1, Opioid receptor kappa |
Target Sequences: | NM_000912 NP_000903.2 P41145 |
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.